1,3-dipropyl-8-cyclopentylxanthine has been researched along with Urinary Bladder Neoplasms in 1 studies
DPCPX : An oxopurine that is 7H-xanthine substituted at positions 1 and 3 by propyl groups and at position 8 by a cyclohexyl group.
Urinary Bladder Neoplasms: Tumors or cancer of the URINARY BLADDER.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Phelps, PT | 1 |
| Anthes, JC | 1 |
| Correll, CC | 1 |
1 other study available for 1,3-dipropyl-8-cyclopentylxanthine and Urinary Bladder Neoplasms
| Article | Year |
|---|---|
Characterization of adenosine receptors in the human bladder carcinoma T24 cell line.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Calcium; Cell Line, Tumor; Cyclic AMP; Dose-Response R | 2006 |